+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pentasa"

Research Report on China's Mesalazine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Mesalazine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Pentasa Enema - API Insight, 2022 - Product Thumbnail Image

Pentasa Enema - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Pentasa Enema- Drug Insight, 2019 - Product Thumbnail Image

Pentasa Enema- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Pentasa is a brand of mesalamine, an anti-inflammatory drug used to treat ulcerative colitis, Crohn's disease, and other gastrointestinal disorders. It is a member of the aminosalicylate class of drugs, which are used to reduce inflammation in the digestive tract. Pentasa is available in both oral and rectal forms, and is often prescribed in combination with other medications. It is generally well-tolerated, with few side effects. Pentasa is one of the leading medications used to treat gastrointestinal disorders, and is widely prescribed by doctors. It is available in many countries around the world, and is often covered by insurance plans. The market for gastrointestinal drugs is highly competitive, with many companies offering similar products. Some of the major players in the market include AbbVie, AstraZeneca, Pfizer, Merck, and Takeda. Show Less Read more